Business
Liquiband deal with Stryker
Liquiband deal with Stryker.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n RNS Number : 3633V Advanced Medical Solutions Grp PLC 09 July 2009 \n \n\n\n\n\nFor Immediate Release\n\n\n9 July 2009\n\n\n\n\n\nAdvanced Medical Solutions Group plc\n('AMS' or the 'Group')\nGlobal partnership with Stryker for distribution of LiquiBand™ products in Cranio-maxillofacial surgery\n\nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces that it has entered into an agreement with Stryker Corporation ('Stryker') for global marketing and distribution of certain of its LiquiBand™ wound closure products for use in cranio-maxillofacial (CMF) surgical procedures. \n\nStryker is one of the largest players in the $35.6 billion worldwide orthopaedic market with products sold in more than 120 countries. The CMF segment represents $900m of this market with Stryker being globally recognised as the leader in this specialist field which involves surgical procedures resulting from fracture repair and deformity correction in the head and neck.\n\nUnder the terms of the agreement announced today, Stryker will have exclusive marketing and distribution rights for predominantly all geographical markets for CMF, with product launches to the European market, where the products are approved, commencing this month and a phased roll out in the rest of the world following thereafter. Sales by Stryker into the US CMF market are expected to commence later this year following FDA approval of the relevant products. \n\nLiquiBand™ is a range of topical tissue adhesives based on cyanoacrylate adhesive technology developed for medical applications covering the whole spectrum of wound closure in the Emergency Room (ER) and Operating Room (OR). Tissue adhesives offer significant benefits over conventional ways of closing wounds following trauma or surgical incisions. They are simple to use, non-invasive, help to reduce the risk of infection, minimise trauma to the patient and provide good clinical and cosmetic outcomes.\n\nCommenting on this agreement, Dr. Don Evans, Chief Executive Officer of Advanced Medical Solutions, s...